SE7502725L - - Google Patents
Info
- Publication number
- SE7502725L SE7502725L SE7502725A SE7502725A SE7502725L SE 7502725 L SE7502725 L SE 7502725L SE 7502725 A SE7502725 A SE 7502725A SE 7502725 A SE7502725 A SE 7502725A SE 7502725 L SE7502725 L SE 7502725L
- Authority
- SE
- Sweden
- Prior art keywords
- stomach
- active ingredient
- remaining
- gastric
- impregnation
- Prior art date
Links
- 210000002784 stomach Anatomy 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 1
- 210000004051 gastric juice Anatomy 0.000 abstract 1
- 238000005470 impregnation Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000002085 persistent effect Effects 0.000 abstract 1
- 239000002831 pharmacologic agent Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 208000018556 stomach disease Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2767374A JPS5512411B2 (zh) | 1974-03-12 | 1974-03-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7502725L true SE7502725L (zh) | 1975-09-15 |
SE409286B SE409286B (sv) | 1979-08-13 |
Family
ID=12227459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7502725A SE409286B (sv) | 1974-03-12 | 1975-03-11 | Sett att framstella en fast, terapeutisk beredning for oralt bruk |
Country Status (12)
Country | Link |
---|---|
US (1) | US3976764A (zh) |
JP (1) | JPS5512411B2 (zh) |
BE (1) | BE826498A (zh) |
CA (1) | CA1054056A (zh) |
CH (1) | CH604719A5 (zh) |
DE (1) | DE2510620C2 (zh) |
DK (1) | DK142802B (zh) |
ES (1) | ES435500A1 (zh) |
FR (1) | FR2263744B1 (zh) |
GB (1) | GB1507521A (zh) |
NL (1) | NL7502952A (zh) |
SE (1) | SE409286B (zh) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
US4207890A (en) * | 1977-01-04 | 1980-06-17 | Mcneilab, Inc. | Drug-dispensing device and method |
JPS6024767B2 (ja) * | 1979-08-24 | 1985-06-14 | 塩野義製薬株式会社 | 腸溶性硬カプセル剤 |
JPS58501128A (ja) * | 1981-07-15 | 1983-07-14 | キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド | 徐放性テオフイリン |
US4451260A (en) * | 1982-03-26 | 1984-05-29 | Minnesota Mining And Manufacturing Company | Sustained release oral medicinal delivery device |
JPS5953410A (ja) * | 1982-09-20 | 1984-03-28 | Fujisawa Pharmaceut Co Ltd | 新型ソフトカプセル剤 |
JPS59193831A (ja) * | 1983-04-18 | 1984-11-02 | Sankyo Co Ltd | 腸溶性製剤の製造法 |
US4505890A (en) * | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
JPS61107782U (zh) * | 1984-12-19 | 1986-07-08 | ||
US4735804A (en) * | 1985-05-10 | 1988-04-05 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4758436A (en) * | 1985-05-29 | 1988-07-19 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4767627A (en) * | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4666705A (en) * | 1985-06-03 | 1987-05-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4756911A (en) * | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
DE3803482A1 (de) * | 1988-02-05 | 1989-08-17 | Lohmann Therapie Syst Lts | Schwimmfaehiges orales therapeutisches system |
JPH082781B2 (ja) * | 1988-10-18 | 1996-01-17 | 嘉明 川島 | 中空顆粒状医薬及びその製法 |
CA2085585A1 (en) * | 1990-06-25 | 1991-12-26 | George Torosian | Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
US5198229A (en) * | 1991-06-05 | 1993-03-30 | Alza Corporation | Self-retaining gastrointestinal delivery device |
US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
DE4406424A1 (de) | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
JP2671257B2 (ja) * | 1995-07-13 | 1997-10-29 | エーザイ株式会社 | 溶解遅延性ゼラチン製剤組成物 |
SE9702533D0 (sv) | 1997-07-01 | 1997-07-01 | Astra Ab | New oral formulation |
IN186245B (zh) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
CN1203846C (zh) | 1998-03-19 | 2005-06-01 | 布里斯托尔-迈尔斯斯奎布公司 | 高溶解性药物的双相控释递送系统和方法 |
EP1245227A1 (en) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
US20030203027A1 (en) * | 2002-04-26 | 2003-10-30 | Ethicon, Inc. | Coating technique for deposition of drug substance on a substrate |
US20040086566A1 (en) * | 2002-11-04 | 2004-05-06 | Alpharma, Inc. | Waxy matrix dosage forms |
US7485322B2 (en) * | 2002-12-24 | 2009-02-03 | Lek Pharmaceuticals D.D. | Modified release pharmaceutical composition |
SI1596841T1 (sl) * | 2003-02-21 | 2009-06-30 | Lek Pharmaceuticals D.D. | Terapevtski sistem amoksicilina in klavulanske kisline |
AU2004289221B2 (en) * | 2003-11-04 | 2009-12-17 | Supernus Pharmaceuticals, Inc | Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
BRPI0716481A2 (pt) * | 2006-09-04 | 2014-03-18 | Panacea Biotec Ltd | Tecnologia de liberação flutuante programável |
WO2009087665A2 (en) * | 2007-12-11 | 2009-07-16 | Vishwanath Sudhir Nande | Novel gastroretentive drug delivery system |
GB2460915B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
JP2012500230A (ja) * | 2008-08-18 | 2012-01-05 | 北京天衡▲薬▼物研究院 | 胃内滞留薬物放出システム及びその製造方法と使用 |
FR2945945B1 (fr) * | 2009-05-29 | 2011-07-29 | Flamel Tech Sa | Procede de preparation de particules creuses et leurs applications |
FR2945947B1 (fr) | 2009-05-29 | 2011-07-29 | Flamel Tech Sa | Compositions pharmaceutiques flottantes a liberation controlee |
US20120100212A1 (en) * | 2009-07-06 | 2012-04-26 | Kyorin Pharmaceutical, Co., Ltd. | Tablet having hollow structure |
WO2012004231A1 (en) * | 2010-07-05 | 2012-01-12 | Jagotec Ag | Dosage form |
EP2731609A1 (en) * | 2011-07-14 | 2014-05-21 | APeT Holding B.V. | Nicotinamide compositions and the therapeutic use thereof |
AU2012322323B2 (en) | 2011-10-11 | 2016-04-21 | Sun Pharmaceutical Industries Limited | A gastroretentive dosage system and process of preparation thereof |
CA3149459A1 (en) * | 2012-07-16 | 2014-01-23 | APET Holding B.V. | Gastro-retentive drug delivery system |
EP2719376B1 (en) | 2012-10-12 | 2015-03-04 | Omya International AG | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
EP3155024B1 (en) | 2014-06-11 | 2020-09-16 | Massachusetts Institute Of Technology | Residence structures and related methods |
EP3034070A1 (en) | 2014-12-18 | 2016-06-22 | Omya International AG | Method for the production of a pharmaceutical delivery system |
CN104706613B (zh) * | 2015-03-20 | 2018-01-16 | 华侨大学 | 一种胃漂浮空心缓释片的制备方法 |
EP3069713A1 (en) | 2015-03-20 | 2016-09-21 | Omya International AG | Dispersible dosage form |
CA2983272C (en) | 2015-05-01 | 2023-08-29 | Massachusetts Institute Of Technology | Triggerable shape memory induction devices |
JP7085473B2 (ja) | 2015-10-23 | 2022-06-16 | リンドラ セラピューティクス, インコーポレイティド | 治療薬の持続放出用の胃内滞留システム及びその使用方法 |
KR20180090881A (ko) | 2015-12-08 | 2018-08-13 | 린드라 인코퍼레이티드 | 위 체류 시스템을 위한 기하 구성형태 |
EP3429556A1 (en) * | 2016-03-18 | 2019-01-23 | Grünenthal GmbH | Floating pharmaceutical dosage form |
EP3269361A1 (en) | 2016-07-14 | 2018-01-17 | Omya International AG | Dosage form |
US11576866B2 (en) | 2016-09-30 | 2023-02-14 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
WO2023166225A1 (en) * | 2022-03-04 | 2023-09-07 | APET Holding B.V. | Digestive enzyme formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3418999A (en) * | 1964-02-12 | 1968-12-31 | Donald W. Davis | Method of swallowing a pill |
FR1454013A (fr) * | 1965-08-18 | 1966-07-22 | Pluripharm | Mode de présentation de deux médicaments associés |
US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
-
1974
- 1974-03-12 JP JP2767374A patent/JPS5512411B2/ja not_active Expired
-
1975
- 1975-03-10 FR FR7507336A patent/FR2263744B1/fr not_active Expired
- 1975-03-10 BE BE154189A patent/BE826498A/xx not_active IP Right Cessation
- 1975-03-11 SE SE7502725A patent/SE409286B/xx not_active IP Right Cessation
- 1975-03-11 ES ES435500A patent/ES435500A1/es not_active Expired
- 1975-03-11 US US05/557,408 patent/US3976764A/en not_active Expired - Lifetime
- 1975-03-11 DK DK97875AA patent/DK142802B/da not_active IP Right Cessation
- 1975-03-11 DE DE2510620A patent/DE2510620C2/de not_active Expired
- 1975-03-12 CA CA221,903A patent/CA1054056A/en not_active Expired
- 1975-03-12 GB GB10214/75A patent/GB1507521A/en not_active Expired
- 1975-03-12 NL NL7502952A patent/NL7502952A/xx not_active Application Discontinuation
- 1975-03-12 CH CH315475A patent/CH604719A5/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CH604719A5 (zh) | 1978-09-15 |
NL7502952A (nl) | 1975-09-16 |
DE2510620A1 (de) | 1975-09-18 |
SE409286B (sv) | 1979-08-13 |
CA1054056A (en) | 1979-05-08 |
JPS50121418A (zh) | 1975-09-23 |
ES435500A1 (es) | 1977-02-01 |
JPS5512411B2 (zh) | 1980-04-02 |
DK97875A (zh) | 1975-09-13 |
DK142802B (da) | 1981-02-02 |
US3976764A (en) | 1976-08-24 |
FR2263744B1 (zh) | 1978-11-24 |
DK142802C (zh) | 1981-09-21 |
BE826498A (fr) | 1975-06-30 |
DE2510620C2 (de) | 1984-01-05 |
GB1507521A (en) | 1978-04-19 |
FR2263744A1 (zh) | 1975-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7502725L (zh) | ||
CA984709A (en) | Apparatuses for disintegration of straw and similar material | |
JPS57109715A (en) | Rapid decaying compression molded article containing pharmaceutically active substance | |
JPS567724A (en) | Blend and its manufacture | |
AU470023B2 (en) | Layered bolus for animal husbandry providing for immediate and sustained release of medicament | |
JPS5572117A (en) | Analgesic tablet and its manufacture | |
AU457051B2 (en) | Improvements relating to in vitro determination of active substance in a body | |
JPS5442380A (en) | Regenerative capsule | |
GB630439A (en) | Improvements in or relating to pharmaceutical preparations | |
SE7407561L (zh) | ||
JPS577422A (en) | Crocosmia aurea "plach" | |
JPS52130905A (en) | Medicinal composition | |
AU457088B2 (en) | Controlled feeding of powdered material | |
KR790000108B1 (en) | Method for preparation of collapsible gelatine medical capsules | |
JPS5350319A (en) | Drug discharging means of medical capsule | |
CA1007925A (en) | Artificial roughage materials | |
JPS5678071A (en) | Positive plate for lead acid battery | |
JPS5423117A (en) | Hard capsule | |
JPS56127312A (en) | Drug for remedy of hepatic disease and recovery from fatigue | |
FR2150351A1 (en) | Tubular accumulator electrode - filled with active powder material fluidized with silicic acid | |
KE2550A (en) | Process for the bulk culture of foot and mouth disease viruses | |
GB841633A (en) | Pharmaceutical composition for use in treatment of helminths | |
IL40311A (en) | Pharmaceutical preparation for the treatment of gastro-intestinal troubles containing phanquone and furazolidone | |
CS180128B1 (en) | Nutritive preparation,especially for feeding of calves and mode of its manufacture | |
CA873451A (en) | Shell for the immobilization of animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7502725-0 Effective date: 19931008 Format of ref document f/p: F |